NCR1 and melanoma: In another cohort of ipilimumab-treated advanced melanoma patients, NK cells shifted toward a mature CD56dim phenotype expressing increased NKp46 and TIM-3 and decreased inhibitory killer Ig-like receptors (KIRs).